EUVIMEDEUVIMED entdecken
Crossref

Anoikis‐related signature in liver hepatocellular carcinoma defines the YBX1/SPP1 axis by machine learning strategies and valid experiments

Ying Ma, Xingguo She, Jie Zhao, Shu Liu, Cai Li, Qiang Wang

The Journal of Gene Medicine · 2023

DOI: 10.1002/jgm.3516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2023. Verfasst von Ying Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Transplantation Center of the Third Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver hepatocellular carcinoma (LIHC) remains a malignant malignancy with a low cure rate. Anoikis is a newly recognized cancer hallmark. However, an Anoikis‐related model has not been clarified in LIHC.

Methods

The Anoikis‐related score in the present study was created using Survival Random Forest and least absolute shrinkage and selection operator (LASSO) machine learning algorithms. Anoikis‐related scores with respect to mutation analysis, immunological analysis, function annotation, and medication prediction were all thoroughly investigated.

Results

The Anoikis‐related score accurately predicted the patients' immunological activity, altered genes, and medication sensitivity. SPP1 immunological analysis, function annotation, medication prediction, and immunotherapy prediction were systematically investigated. SPP1 may effectively predict the outcomes of immunotherapy. SPP1 was revealed to be a mediator of LIHC cell proliferation and migration. A putative axis in LIHC was YBX1/SPP1.

Conclusions

Clinical care and the treatment plan for patients with LIHC were anticipated to benefit significantly from the established Anoikis‐related score.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansAnoikisMachine LearningY-Box-Binding Protein 1Osteopontin

Stichwörter der Autor:innen

AnoikisLIHCimmunotherapymachine learningtumor microenvironment

Substanzen

YBX1 protein, humanY-Box-Binding Protein 1SPP1 protein, humanOsteopontin

Autor:innen und Institutionen

  • The Transplantation Center of the Third Xiangya Hospital, Central South University, Changsha, China.
  • Engineering and Technology Research Center for Transplantation Medicine of National Health Comission, Changsha, China.
  • Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Zitieren

APA

Ma, Y., She, X., Zhao, J., Liu, S., Li, C., & Wang, Q. (2023). Anoikis‐related signature in liver hepatocellular carcinoma defines the YBX1/SPP1 axis by machine learning strategies and valid experiments. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3516

Vancouver

Ma Y, She X, Zhao J, Liu S, Li C, Wang Q. Anoikis‐related signature in liver hepatocellular carcinoma defines the YBX1/SPP1 axis by machine learning strategies and valid experiments. The Journal of Gene Medicine. 2023. doi:10.1002/jgm.3516

BibTeX
@article{Ma2023,
  author = {Ma, Ying and She, Xingguo and Zhao, Jie and Liu, Shu and Li, Cai and Wang, Qiang},
  title = {Anoikis‐related signature in liver hepatocellular carcinoma defines the YBX1/SPP1 axis by machine learning strategies and valid experiments},
  journal = {The Journal of Gene Medicine},
  year = {2023},
  doi = {10.1002/jgm.3516}
}
Kostenlos starten →